{"id":"nct:NCT01798537","kind":"trial","title":"Simplified Selective Digestive Tract Decontamination for the Prevention of Intensive Care Unit Acquired Infections","authors":["Rambam Health Care Campus"],"author_count":1,"year":2013,"published":"2013-02-26","venue":"ClinicalTrials.gov","cited_by":null,"doi":null,"arxiv_id":null,"nct_id":"NCT01798537","source_url":"https://clinicaltrials.gov/study/NCT01798537","archive_url":"https://space-kitty.com/papers/nct:NCT01798537","updated":"2013-02-26","pmid":null,"pmcid":null,"openalex_id":null,"pdf_url":null,"abstract":"A simplified graded gut decontamination protocol combined with rigorous bi-weekly screening and appropriate bacterial prophylaxis, will lead to a 25% reduction in the acquisition of blood stream infections and to a 25% reduction in lower airway colonization with multi drug resistant organisms. There will be no concomitant rise in gram-positive or fungal infection or a surgency of new resistance patterns.","abstract_license":"ClinicalTrials.gov (U.S. National Library of Medicine), data processed 2026-10-29T09:00:05; modifications: selected fields only; whitespace normalized; brief summary truncated to 2,000 characters","license":"ClinicalTrials.gov terms (attribution, processing date, modifications noted)","is_open_access":true,"retracted":false,"peer_reviewed":null,"categories":["Bacteremia Associated With Intravascular Line","Ventilator Associated Pneumonia","Bacteremia"],"details":{"acronym":"SDDICU","status":"UNKNOWN","phase":"PHASE2, PHASE3","study_type":"INTERVENTIONAL","enrollment":2400,"sponsor":"Rambam Health Care Campus","conditions":["Bacteremia Associated With Intravascular Line","Ventilator Associated Pneumonia","Bacteremia"],"interventions":["DRUG: Neomycin Colistin Nystatin Vancomycin"],"start_date":"2013-06-01","start_date_type":null,"primary_completion_date":"2015-07-01","has_results":false,"data_source":"ClinicalTrials.gov","data_processed":"2026-10-29T09:00:05","modifications":"selected fields only; whitespace normalized; brief summary truncated to 2,000 characters"},"provenance":"clinicaltrials","attribution":"Source: ClinicalTrials.gov (U.S. National Library of Medicine), data processed 2026-10-29T09:00:05; modifications: selected fields only; whitespace normalized; brief summary truncated to 2,000 characters. Not a U.S. Government endorsement.","topics":[{"slug":"infectious-disease-amr","name":"Infectious Disease, Vaccines & Antimicrobial Resistance","domain_slug":"medicine"}],"cited_in_dossiers":[]}